The Molecular Imaging and Nanotechnology Laboratory at the University of Wisconsin - Madison (http://mi.wisc.edu/) is mainly focused on three areas: 1) development of multimodality molecular imaging agents; 2) nanobiotechnology and its biomedical applications; and 3) molecular therapy of cancer and various other diseases. In this talk, I will present our representative work on imaging, image-guided drug delivery, and theranostics of cancer and other diseases with a variety of nanomaterials. The primary imaging techniques used in these studies are positron emission tomography (PET), photoacoustic tomography (PAT), optical imaging, and magnetic resonance imaging (MRI). The nanomaterials that will be discussed in this presentation may include silica-based nanoparticles, DNA nanomaterials, nanovaccines, micelles, iron oxide nanoparticles, 2-D nanomaterials, hybrid nanomaterials, among others.



Weibo Cai is a Vilas Distinguished Achievement Professor of Radiology, Medical Physics, Materials Science & Engineering, and Pharmaceutical Sciences at the University of Wisconsin - Madison. He received a BS degree in Chemistry from Nanjing University, China (1995) and a PhD degree in Chemistry from the University of California San Diego (2004). Between 2005 and 2008, Dr. Cai did his post-doctoral research in the Molecular Imaging Program at Stanford University. In February 2008, Dr. Cai joined the University of Wisconsin - Madison as a Biomedical Engineering Cluster Hire, and was promoted to Associate Professor with Tenure in 2014, and Full Professor in 2018. Dr. Cai’s research at UW-Madison (http://mi.wisc.edu) is primarily focused on molecular imaging and nanobiotechnology.

Dr. Cai has authored >360 peer-reviewed articles (total citation: >33,000 times; h-index: 96), edited 3 books, and given >280 talks. Dr. Cai has received many awards, including the European Association of Nuclear Medicine (EANM) Springer Prize (2011 & 2013), American Cancer Society Research Scholar (2013-2017), EANM Annual Congress Plenary Lecturer (2016), Inaugural Nano Research Young Innovators (NR45) in Nanobiotechnology Award (2018), Fellow of American Institute for Medical and Biological Engineering (AIMBE, 2018), Highly Cited Researchers from Clarivate Analytics (Cross-Field, 2018), Fellow of the Society of Nuclear Medicine and Molecular Imaging (SNMMI, 2019), Fellow of Royal Society of Chemistry (RSC, 2021), SNMMI Radiopharmaceutical Sciences Council’s Michael J. Welch Award (2022), among others.

About AIBN Seminar Series

The AIBN Seminar series showcases a range of seminars across different topics and disciplines